DISEASE MODIFYING GENES IN SEVERE ASTHMA
严重哮喘的疾病修饰基因
基本信息
- 批准号:7718395
- 负责人:
- 金额:$ 0.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Asthma is a heterogeneous disease in adults, with some expressing mild disease, whereas others have severe symptoms. Some adults with asthma progress to severe irreversible airway obstruction, whereas other maintain airway function. The investigators have identified a large cohort of patients with atopy and persistent airway obstruction in their urban clinic of adult patients with asthma. The question arises, therefore, whether in the atopic subject with asthma, there are disease modifying genes that predispose to the development of irreversible airway obstruction. The global aim of this proposal will be to test the hypothesis that in a susceptible host, there are disease-modifying genes that modulate the response to the repetitive allergic inflammatory injury. The focus will be to define precise physiologic phenotypes of severe asthma and to test the association between allelic variants in airway/matrix remodeling genes and the defined severe phenotypes. More specifically, the study's aims are as follows: 1) To identify specific physiologic phenotypes of "severe asthma" defined by spirometry, plethysmography and measurement of elastic recoil properties of the lung. 2.)To test the hypothesis that asthma susceptibility as determined by IgE (total and allergen-specific) discriminates the physiologic phenotypes of severe asthma. 3) To test the hypothesis that polymorphisms of matrix remodeling genes are associated with physiologic phenotypes of severe asthma (disease-modifying genes).
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
哮喘是成年人的一种异质性疾病,有些表达轻度疾病,而另一些则具有严重的症状。一些患有哮喘的成年人会发展为严重的不可逆气道阻塞,而另一些则保持气道功能。 研究人员已经确定了大量的成年哮喘患者城市诊所中有特应性和持续气道阻塞的患者。因此,出现的问题是,在患有哮喘的特征性受试者中是否会改变疾病,使基因易不可逆的气道阻塞的发展。该提案的全球目的是检验以下假设:在易感宿主中,有一些疾病改良的基因调节对重复过敏性炎症性损伤的反应。重点是定义严重哮喘的精确生理表型,并测试气道/基质重塑基因中的等位基因变体与定义的严重表型之间的关联。 更具体地说,该研究的目的如下:1)确定由肺活量测定法,杂质学和测量肺弹性后坐力特性定义的“严重哮喘”的特定生理表型。 2.)检验以下假设:由IgE(总和特异性和过敏原)确定的哮喘易感性可以区分严重哮喘的生理表型。 3)检验以下假设,即基质重塑基因的多态性与严重哮喘(疾病调整基因)的生理表型有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
JOAN REIBMAN的其他基金
Cognitive decline among WTC survivors with chronic mental and physical disorders
患有慢性精神和身体疾病的世贸中心幸存者认知能力下降
- 批准号:1068377910683779
- 财政年份:2022
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Cognitive decline among WTC survivors with chronic mental and physical disorders
患有慢性精神和身体疾病的世贸中心幸存者认知能力下降
- 批准号:1053596410535964
- 财政年份:2022
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program
世贸中心幸存者计划中不受控制的下呼吸道症状
- 批准号:86954428695442
- 财政年份:2013
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
STUDY OF ACID REFLUX ASTHMA (SARA)
胃酸反流性哮喘 (SARA) 的研究
- 批准号:77184297718429
- 财政年份:2008
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
BRONCHOALVEOLAR LAVAGE AND BRUSHINGS IN NORMALS
正常情况下的支气管肺泡灌洗和刷洗
- 批准号:77183787718378
- 财政年份:2008
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
WORLD TRADE CENTER NON-RESPONDER PROGRAM NEW YORK CITY HEALTH AND HOSPITALS CORPO
世界贸易中心无应答者计划 纽约市健康与医院公司
- 批准号:79322587932258
- 财政年份:2008
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
WORLD TRADE CENTER NON-RESPONDER PROGRAM NEW YORK CITY HEALTH AND HOSPITALS CORPO
世界贸易中心无应答者计划 纽约市健康与医院公司
- 批准号:76955777695577
- 财政年份:2008
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
BLOOD-DERIVED DENDRITIC CELLS AND EPITHELIAL CELLS
血源性树突状细胞和上皮细胞
- 批准号:77184097718409
- 财政年份:2008
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
STUDY OF ACID REFLUX ASTHMA (SARA)
胃酸反流性哮喘 (SARA) 的研究
- 批准号:76057457605745
- 财政年份:2007
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
BLOOD-DERIVED DENDRITIC CELLS AND EPITHELIAL CELLS
血源性树突状细胞和上皮细胞
- 批准号:76057187605718
- 财政年份:2007
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
相似国自然基金
花生主要过敏原 Ara h 3 致敏的结构生物学基础
- 批准号:32372441
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
鱼类过敏原小清蛋白广谱性模拟抗原的精准构筑及构效关系研究
- 批准号:32372439
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
过敏原特异性Th2记忆前体细胞鉴定及其形成机制研究
- 批准号:82371740
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
白色念珠菌过敏原通过CGRP-IL-21-PIEZO1轴促进T细胞-小胶质细胞-神经元通讯介导瘙痒
- 批准号:82371797
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
过敏原RNA疫苗促进过敏性鼻炎中嗜酸性粒细胞分泌保护素D1诱导Treg产生机制
- 批准号:82371122
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:1055118410551184
- 财政年份:2023
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:1067830710678307
- 财政年份:2023
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
- 批准号:1067730410677304
- 财政年份:2023
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Interplay of the T Cell Repertoire Development and Early Life Exposure on Incident Risk of Peanut Allergy
T 细胞库发育和生命早期接触对花生过敏事件风险的相互作用
- 批准号:1074202910742029
- 财政年份:2023
- 资助金额:$ 0.47万$ 0.47万
- 项目类别:
Impact of Maternal Arsenic Exposure on Offspring's Epigenetic Reprogramming of Allergic Airway Disease
母亲砷暴露对后代过敏性气道疾病表观遗传重编程的影响
- 批准号:1073360710733607
- 财政年份:2023
- 资助金额:$ 0.47万$ 0.47万
- 项目类别: